marketwire.com
20-May-2008
LONDON--(Marketwire - May 20, 2008) - SkyePharma Announces Presentation of FlutiformTM Phase III Safety Study at ATS in Toronto LONDON, UK, 20 May, 2008 - SkyePharma PLC (LSE: SKP) today announces the presentation of its Phase III, long-term, open label safety study evaluating FlutiformTM for the...
[read full story]